Molecular and Clinical Nutrition Section, Digestive Diseases Branch Intramural Research Program, Bethesda, MD, USA.
Suntech Research Institutes, Rockville, MD, USA.
Am J Clin Nutr. 2022 Jul 6;116(1):274-284. doi: 10.1093/ajcn/nqac063.
Diabetes is associated with low plasma vitamin C concentrations.
We investigated the contribution of dysregulated vitamin C renal physiology, its prevalence, and associated clinical characteristics.
An essential prerequisite was determination of normal vitamin C renal threshold, the plasma concentration at which vitamin C first appears in urine. Using data from 17 healthy participants who underwent vitamin C depletion-repletion studies with a vitamin C dose range of 15-1250 mg daily, renal threshold was estimated using physiology-based pharmacokinetics modeling. Applying renal threshold 95% CIs, we estimated the minimal elimination threshold, the plasma concentration below which no vitamin C was expected in urine of healthy people. Renal leak was defined as abnormal presence of vitamin C in urine with plasma concentrations below the minimal elimination threshold. Criteria were tested in a cross-sectional cohort study of individuals with diabetes (82) and nondiabetic controls (80) using matched plasma and urine samples.
Vitamin C renal thresholds in healthy men and women were [mean (SD)] 48.5 (5.2) µM and 58.3 (7.5) µM, respectively. Compared with nondiabetic controls, participants with diabetes had significantly higher prevalence of vitamin C renal leak (9% compared with 33%; OR: 5.07; 95% CI: 1.97, 14.83; P < 0.001) and 30% lower mean plasma vitamin C concentrations (53.1 µM compared with 40.9 µM, P < 0.001). Fasting plasma glucose, glycosylated hemoglobin A1c, BMI, micro/macrovascular complications, and protein/creatinine ratio were predictive of vitamin C renal leak.
Increased prevalence of vitamin C renal leak in diabetes is associated with reduced plasma vitamin C concentrations. Glycemic control, microvascular complications, obesity, and proteinuria are predictive of renal leak.
糖尿病与血浆维生素 C 浓度降低有关。
我们研究了维生素 C 肾生理学失调的贡献、其患病率以及相关的临床特征。
一个必要的前提是确定正常的维生素 C 肾阈,即尿液中首次出现维生素 C 的血浆浓度。我们使用 17 名健康参与者的维生素 C 耗竭-补充研究数据,这些参与者每日接受 15-1250mg 的维生素 C 剂量,使用基于生理学的药代动力学模型估算肾阈。应用肾阈 95%CI,我们估计最小消除阈值,即健康人尿液中预计不会出现维生素 C 的血浆浓度。肾漏定义为在低于最小消除阈值的血浆浓度下,尿液中出现异常的维生素 C。使用糖尿病(82 名)和非糖尿病对照(80 名)的横断面队列研究来测试这些标准,同时使用匹配的血浆和尿液样本。
健康男性和女性的维生素 C 肾阈分别为[平均值(SD)]48.5(5.2)µM 和 58.3(7.5)µM。与非糖尿病对照组相比,糖尿病参与者的维生素 C 肾漏患病率明显更高(9%比 33%;OR:5.07;95%CI:1.97,14.83;P<0.001),且平均血浆维生素 C 浓度低 30%(53.1µM 比 40.9µM,P<0.001)。空腹血糖、糖化血红蛋白 A1c、BMI、微血管/大血管并发症以及蛋白/肌酐比值可预测维生素 C 肾漏。
糖尿病中维生素 C 肾漏的患病率增加与血浆维生素 C 浓度降低有关。血糖控制、微血管并发症、肥胖和蛋白尿是肾漏的预测因素。